These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7290360)

  • 21. Opiate antagonists and eating behavior in humans: a review.
    de Zwaan M; Mitchell JE
    J Clin Pharmacol; 1992 Dec; 32(12):1060-72. PubMed ID: 1487543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of deprivation-induced water intake in the rat by opioid antagonists: central sites of action.
    Ukai M; Holtzman SG
    Psychopharmacology (Berl); 1987; 91(3):279-84. PubMed ID: 3104950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central opioid receptor subtype mediation of isoproterenol-induced drinking in rats.
    Glass MJ; Hahn B; Joseph A; Bodnar RJ
    Brain Res; 1994 Sep; 657(1-2):310-4. PubMed ID: 7820634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modifications in food intake and energy metabolism in rats as a function of chronic naltrexone infusions.
    Marks-Kaufman R; Balmagiya T; Gross E
    Pharmacol Biochem Behav; 1984 Jun; 20(6):911-6. PubMed ID: 6431449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of anorexic doses of dextro-amphetamine on the ventromedial-hypothalamic hyperphagic rat.
    Wishart TB; Walls EK
    Can J Physiol Pharmacol; 1973 May; 51(5):354-9. PubMed ID: 4583556
    [No Abstract]   [Full Text] [Related]  

  • 26. Analysis of central opioid receptor subtype antagonism of hypotonic and hypertonic saline intake in water-deprived rats.
    Bodnar RJ; Glass MJ; Koch JE
    Brain Res Bull; 1995; 36(3):293-300. PubMed ID: 7697383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute opioid pretreatment potentiates naltrexone-induced drinking suppression in water-deprived rats.
    White DA; Holtzman SG
    J Pharmacol Exp Ther; 2001 Jul; 298(1):156-64. PubMed ID: 11408537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of naloxone and naltrexone on meal patterns of freely-feeding rats.
    Kirkham TC; Blundell JE
    Pharmacol Biochem Behav; 1987 Mar; 26(3):515-20. PubMed ID: 3575366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of naltrexone on food intake and body weight gain in olanzapine-treated rats.
    Kurbanov DB; Currie PJ; Simonson DC; Borsook D; Elman I
    J Psychopharmacol; 2012 Sep; 26(9):1244-51. PubMed ID: 22723540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous administration of oxytocin in rats acutely decreases deprivation-induced chow intake, but it fails to affect consumption of palatable solutions.
    Klockars A; Brunton C; Li L; Levine AS; Olszewski PK
    Peptides; 2017 Jul; 93():13-19. PubMed ID: 28460894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of amylin and bupropion/naltrexone on food intake and body weight are interactive in rodent models.
    Clapper JR; Athanacio J; Wittmer C; Griffin PS; D'Souza L; Parkes DG; Roth JD
    Eur J Pharmacol; 2013 Jan; 698(1-3):292-8. PubMed ID: 23178527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naloxone's anorectic effect is dependent upon the relative palatability of food.
    Giraudo SQ; Grace MK; Welch CC; Billington CJ; Levine AS
    Pharmacol Biochem Behav; 1993 Dec; 46(4):917-21. PubMed ID: 8309972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of deprivation-induced food and water intake in rats and mice by naloxone.
    Brown DR; Holtzman SG
    Pharmacol Biochem Behav; 1979 Nov; 11(5):567-73. PubMed ID: 531080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined naloxone and fluoxetine on deprivation-induced binge eating of palatable foods in rats.
    Hagan MM; Holguin FD; Cabello CE; Hanscom DR; Moss DE
    Pharmacol Biochem Behav; 1997 Dec; 58(4):1103-7. PubMed ID: 9408220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of drinking by naloxone in rats homo- and heterozygous for diabetes insipidus.
    Brown DR; Holtzman SG
    Pharmacol Biochem Behav; 1981 Jul; 15(1):109-14. PubMed ID: 7291218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of naloxone and naltrexone on the development of satiation measured in the runway: comparisons with d-amphetamine and d-fenfluramine.
    Kirkham TC; Blundell JE
    Pharmacol Biochem Behav; 1986 Jul; 25(1):123-8. PubMed ID: 3749218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apomorphine markedly potentiates naltrexone-induced hypodipsia in the rat.
    Ukai M; Nakayama S; Kameyama T
    Brain Res; 1988 Jun; 451(1-2):357-60. PubMed ID: 3251596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alcohol drinking is reduced by a mu 1- but not by a delta-opioid receptor antagonist in alcohol-preferring rats.
    Honkanen A; Vilamo L; Wegelius K; Sarviharju M; Hyytiä P; Korpi ER
    Eur J Pharmacol; 1996 May; 304(1-3):7-13. PubMed ID: 8813578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term treatment of obese Zucker rats with LY255582 and other appetite suppressants.
    Shaw WN
    Pharmacol Biochem Behav; 1993 Nov; 46(3):653-9. PubMed ID: 8278442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of effects of chronic administration of naloxone and naloxonazine upon food intake and maintainance of body weight in rats.
    Mann PE; Pasternak GW; Hahn EF; Curreri G; Lubin E; Bodnar RJ
    Neuropharmacology; 1988 Apr; 27(4):349-55. PubMed ID: 3419536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.